Ligong Lu

12.3k total citations · 3 hit papers
226 papers, 6.4k citations indexed

About

Ligong Lu is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Ligong Lu has authored 226 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 65 papers in Hepatology and 49 papers in Oncology. Recurrent topics in Ligong Lu's work include Hepatocellular Carcinoma Treatment and Prognosis (57 papers), Nanoplatforms for cancer theranostics (32 papers) and Cancer Mechanisms and Therapy (20 papers). Ligong Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (57 papers), Nanoplatforms for cancer theranostics (32 papers) and Cancer Mechanisms and Therapy (20 papers). Ligong Lu collaborates with scholars based in China, United States and Macao. Ligong Lu's co-authors include Meixiao Zhan, Xu He, Wei Zhao, You‐Wen He, Danielle J. Dauphars, Shaojun Peng, Hui Zhang, Sirui Fu, Yongjie Xin and Xiaoyun Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Medicine.

In The Last Decade

Ligong Lu

219 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model

2018 402 citations Ligong Lu et al. profile →
γδ T cells: origin and fate, subsets, diseases and immunotherapy

2023 152 citations Ligong Lu et al. profile →
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell

2023 105 citations Ligong Lu, Peng Li et al. profile →

Peers

Ligong Lu

ONCOL

HEPAT

Jai Prakash Netherlands

Yifan Wang China

Xizhong Shen China

Grietje Molema Netherlands

Xiao Xu China

Giuseppe Toffoli Italy

Lin Zhou China

Weijia Zhang China

Rajesh Singh United States

Liang Chen China

Jai Prakash Netherlands

Ligong Lu

1.8k ×0.8

1.6k ×1.1

568 ×0.5

1.5k ×1.4

ONCOL

723 ×0.8

HEPAT

Citations per year, relative to Ligong Lu Ligong Lu (= 1×) peers Jai Prakash

Countries citing papers authored by Ligong Lu

Since Specialization

Citations

This map shows the geographic impact of Ligong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ligong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligong Lu more than expected).

Fields of papers citing papers by Ligong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ligong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ligong Lu. The network helps show where Ligong Lu may publish in the future.

Co-authorship network of co-authors of Ligong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ligong Lu. A scholar is included among the top collaborators of Ligong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ligong Lu. Ligong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Danyang, Yanyan Liu, Guang Yang, Mingyu He, & Ligong Lu. (2024). Recent insights into RNA m5C methylation modification in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189223–189223. 2 indexed citations

Feng, Xue & Ligong Lu. (2024). Drug-Based Reversal of Drug Resistance in Hepatocellular Carcinoma (HCC) Using TPGS. Journal of Biosciences and Medicines. 12(9). 161–172. 4 indexed citations

Xu, He, et al.. (2024). Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence. Journal of Hepatocellular Carcinoma. Volume 11. 1429–1438. 1 indexed citations

Su, Yanhong, Bing Liu, Binghan Wang, et al.. (2024). Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine. Small. 20(25). e2310342–e2310342. 29 indexed citations

Liu, Bing, Qiuzhong Pan, Meixiao Zhan, et al.. (2024). SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular Cancer Therapeutics. 23(8). 1188–1200. 1 indexed citations

Xiao, Fengfeng, Yongkang Liu, Yanhong Su, et al.. (2024). Biodegradable Poly(amino acid)–Bismuth Nanotheranostic Agents for CT/MR Imaging and Photothermal–Chemodynamic Synergistic Therapy. SHILAP Revista de lepidopterología. 1(5). 448–460. 9 indexed citations

Yu, Xiangrong, Xuejing Li, Qingwang Chen, et al.. (2024). High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC. Advanced Science. 11(15). e2305546–e2305546. 39 indexed citations

Wang, Cheng, Jianjun Zhu, Lifeng Zhu, et al.. (2024). Review of robotic systems for thoracoabdominal puncture interventional surgery. APL Bioengineering. 8(2). 21501–21501. 3 indexed citations

Chan, Leung, Yongkang Liu, Yanhong Su, et al.. (2023). Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu_2‐_xSe via Copper Chemical Transition. Advanced Functional Materials. 33(33). 57 indexed citations

10.

Li, Ke, et al.. (2023). Serum vitamin D deficiency is associated with increased risk of γδ T cell exhaustion in HBV‐infected patients. Immunology. 171(1). 31–44. 4 indexed citations

11.

Zhang, Yanling, Yao He, Shuke Huang, et al.. (2023). A Functional Stent Encapsulating Radionuclide in Temperature‐Memory Spiral Tubes for Malignant Stenosis of Esophageal Cancer. Advanced Materials. 35(52). e2307141–e2307141. 4 indexed citations

12.

Zhan, Meixiao, et al.. (2023). TMSB4X: A novel prognostic marker for non-small cell lung cancer. Heliyon. 9(11). e21505–e21505. 7 indexed citations

13.

Wang, Guangyu, Xiaohong Liu, Kai Wang, et al.. (2023). Deep-learning-enabled protein–protein interaction analysis for prediction of SARS-CoV-2 infectivity and variant evolution. Nature Medicine. 29(8). 2007–2018. 35 indexed citations

14.

Ye, Yi, Xia Xiao, Lingling Hu, et al.. (2023). Definitive Endodermal Cells Supply an in vitro Source of Mesenchymal Stem/Stromal Cells. Communications Biology. 6(1). 476–476. 7 indexed citations

15.

Zhan, Meixiao, Yufeng Ding, Shanzhou� Huang, et al.. (2023). Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nature Communications. 14(1). 3123–3123. 60 indexed citations

16.

Lu, Ligong, Zhiling Zhou, Jinying Lu, et al.. (2022). PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut. 71(12). 2551–2560. 71 indexed citations

17.

Huang, Jianping, Xiao Zhang, Wei Zhao, et al.. (2021). A high resolution representation network with multi-path scale for retinal vessel segmentation. Computer Methods and Programs in Biomedicine. 208. 106206–106206. 35 indexed citations

18.

Sun, Xiaohan, Yan Ding, Meixiao Zhan, et al.. (2019). Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie. Nature Communications. 10(1). 411–411. 72 indexed citations

19.

Lu, Ligong. (2013). Guidance for Individual Administration of Tacrolimus in Kidney-transplanted Patients According to Pregnane X Receptor Genetic Polymorphism. Zhongguo yaofang. 1 indexed citations

20.

Lu, Ligong, et al.. (2012). Clinical observation of transcatheter arterial chemoembolization combined with sorafenib on intermediate-advanced hepatocellular carcinoma. Zhonghua fangshexian yixue zazhi. 46(3). 252–256. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact